Professional Documents
Culture Documents
Department Paediatrics
University of Pretoria
Management principles
Introduction
Calcium homeostasis
Pathophysiology
Albumin
Blood pH Serum phosphate Serum magnesium Serum bicarbonate Exogenous factors
Seizures
Chvostek sign Trousseau sign Prolonged QTc time on ECG
Tetany is not caused by increased excitability of the muscles. Muscle excitability is depressed
However, the increase in neuronal excitability overrides the inhibition of muscle contraction.
Signs & Symptoms: A 2-in-1 Reference for Nurses, Copyright 2007 Lippincott Williams & Wilkins, www.wrongdiagnosis.com/bookimages/14/4721.1.png
Trousseau sign:
(very uncomfortable and painful)
A blood pressure cuff is inflated to a pressure above the patients systolic level. Pressure is continued for several minutes. Carpopedal spasm: * flexion at the wrist * flexion at the MP joints * extension of the IP joints * adduction thumbs/fingers
Long QT interval with normal T waves Prolongation of the ST segment with little shift from the baseline
Children
Prematurity
Poor
intake, hypoalbuminemia, reduced responsiveness to vitamin D feeding, increased calcitonin, endogenous phosphate load high, alkali therapy depletion functional hypoparathyroidism hypocalcemia
Birth asphyxia
Delay
IUGR
Etiology
Magnesium deficiency
Etiology
Hypoparathyroidism
Impaired synthesis / secretion Loss/ lack of PTH tissue or defective synthesis Primary or acquired conditions Defective calcium sensing receptor End organ resistance to PTH (pseudohypoparathyroidism) Hypovitaminosis D (MUCH MORE COMMON)
Hypomagnesemia Other
Genetic
Autosomal dominant Autosomal recessive X-Linked HDR (hypoparathyroidism associated with sensorineural deafness and renal dysplasia) DiGeorge's syndrome ( CATCH 22 ) Mitochondrial disorders:
Synthesis / secretion
Autoimmune
Synthesis / secretion
Acquired
Thyroid surgery Parathyroidectomy Iron deposition with chronic transfusions Wilsons disease Gram negative sepsis, toxic shock, AIDS
? Macrophage-generated cytokines
Pseudohypoparathyroidism
Pseudohypoparathyroidism (PHP)
Expression in tissues either paternally / maternally determined Example: renal expression is maternal
Type 1a PHP
Albrights
Short stature & limbs Obesity Round, flat face Short 4e/5e metacarpals Archibald sign Brachydactyly Potter's thumb Eye problems IQ problems Basal ganglia calcifications
Pseudopseudohypoparathyroidism
Phenotype of Albrights
Pseudohypoparathyroidism
Type 1b
Type 1c
Type 2
No features of Albrights
PHP Ia
Albrights phenotype +
PHP Ib
-
PHP II
-
PPHP
+
Serum calcium
Response to PTH cAMP Response to Phosphorus Hormone Resistance Molecular defect
NL
NL NL None Gsa
Hypovitaminosis D
Increased catabolism
Decrease 25-hydroxylation by liver Decrease 1-hydroxylation by kidney
Delayed closure of fontanels Bossing Craniotabes Delayed eruption of teeth Rickety rosary Pectus carinatum Harrison sulcii Splaying of distal ends of long bones bones Hypotonia Weakness Growth retarded Recurrent chest infections
Hypomagnesemia
Magnesium is required for PTH release May also be required for effects on target organs
Mechanisms:
Hypomagnesemia
Primary
Secondary
Other
Other
After prolonged period of calcium absorption Rebound phase Avid uptake of calcium by bone Parallel uptake of magnesium by bone
Following parathyroidectomy
Workup - blood
Total and ionized calcium Magnesium Phosphate UKE and s-glucose PTH Vitamin D metabolite Urine-CMP and creatinine S-ALP
Workup - imaging
Workup - other
Management
1. 2. 3. 4.
Dependent on the underlying cause and severity Administration of calcium alone is only transiently effective Mild asymptomatic cases: Often adequate to increase dietary calcium by 1000 mg/day Symptomatic: Treat immediately
Treatment of hypocalcaemia
Symptomatic hypocalcaemia
IV Calcium should only be given with close monitoring Should be on cardiac monitor Mix with NaCl or 5 % D/W (not bicarbonate/lactate containing solutions)
Risks
Tissue necrosis/calcification if extravasates Calcium can inhibit sinus node bradycardia + arrest
Avoid complete correction of hypocalcaemia With acidosis and S-Ca give Ca before correcting acidosis If Mg is cause of S-Ca treat and correct hypomagnesaemia
Treatment of hypocalcaemia
Symptomatic hypocalcaemia
Neonates: Ca gluconate:10 mg/kg (1 ml/kg of 10% solution) Slowly IV + monitoring ECG Occasionally associated transient hypomagnesaemia
Start oral Calcium as soon as possible Early neonatal hypocalcaemia normalizes in 2-3 days Oral Ca usually necessary for 1 week
Treatment of hypocalcaemia
Symptomatic hypocalcaemia
Associated with S-phosphate Decrease phosphate intake Give calcium containing phosphate binder Oral calcium (gluconate) supplementation 100 mg/kg/dose 4 hourly per os
Same dose IV as for neonates More often require continuous infusion Oral supplementation 50 mg/kg/24 hr elemental Ca
Ca binds with phosphate in gut Ca absorption Advantage in conditions with s-phosphate
References
Zalman et al. Treatment of hypocalcemia. www.uptodate.com. May 2008. Zalman et al. Diagnostic approach to hypocalcemia. www.uptodate.com. May 2008.
Gernter JM. Disorders of calcium and phosphorus homeostasis. Pediatr Clin North Am. Dec 1990; 37(6): 1441-65.
Lorraine a et al. Hypocalcemia: Diagnosis and Treatment. Metabolic diseases. Sept 2002. Jeha GS et al. Etiology of hypocalcemia in infants and children. www.uptodate.com. May 2008.